Benefits include better discrimination between risk levels. (HealthDay News) — Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current ...

A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach.

TUCSON, Ariz., Sept. 9, 2024 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the expansion of its digital pathology open environment with the integration of more than 20 advanced ...

Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...

A new AI-driven pathology system that automates cancer diagnostics from slide analysis to reporting is now undergoing regulatory review in both Hong Kong and mainland China. The Hong Kong University ...

Cervical cancer is one of the few types of cancers that is highly preventable and can also be cured when diagnosed at an ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most ...

AI has revealed why cancer survival differs so dramatically around the world, highlighting the specific health system factors that matter most in each country.